{
    "2021-08-31": [
        [
            {
                "time": "2023-10-15",
                "original_text": "World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)",
                "features": {
                    "keywords": [
                        "Novartis",
                        "NHS",
                        "agreement",
                        "Leqvio",
                        "cholesterol-lowering"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Novartis signs deal with Britain's NHS for new cholesterol drug Leqvio",
                "features": {
                    "keywords": [
                        "Novartis",
                        "NHS",
                        "deal",
                        "Leqvio",
                        "cholesterol"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}